Associated Papers
The theory of massively repeated evolution and full identifications of cancer-driving nucleotides (CDNs).
Zhang L et al.
Elife, 2024
39688960 (PubMed )
Supplement: elife-99340-supp1.xlsx › CDN.Missense.gnomad
Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3.
Tate T et al.
Cancers, 2023
36831375 (PubMed )
Supplement: cancers-15-01031-s001.zip › Supplementary_Table_S1.xlsx › Table_S1
Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer.
Vlaar JM et al.
Scientific Reports, 2022
The Participation of the Intrinsically Disordered Regions of the bHLH-PAS Transcription Factors in Disease Development.
Kolonko-Adamska M et al.
International Journal of Molecular Sciences, 2021
AhR and Cancer: From Gene Profiling to Targeted Therapy.
Paris A et al.
International Journal of Molecular Sciences, 2021
Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
Shi MJ et al.
Genome Medicine, 2020
Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas.
Wu K et al.
Nature Communications, 2015
26647728 (PubMed )
Supplement: ncomms10131-s8.xlsx › Sup_Data_7
Select a paper to view details